X

Health & Biotech

Genetic Signatures’ mouth-watering TGA nod for saliva-based Omicron testing kit

Among ASX health stocks with news, Genetic Signatures (ASX:GSS) caught the market's attention with an update on its latest COVID-19…

ScoPo’s Powerplays: COVID surge to drive up value in these two ASX health stocks

Omicron has driven up potential value in two stocks, Sonic Healthcare and Healius Morgans downgrades  recommendation of ProMedicus from  “hold’ to…

This fundie reckons MGC Pharma can soar well over 3x current share price

Special Report: Cannacord has a 13.5c price target on MGC Pharma, more than 3x its current stock price. The fundie…

ASX Health Stocks: Crucial new patents have Alterity, Rhythm Biosciences firing in early trade

The ASX 200 Health Index (XHJ) is trading lower by 2% at the time of writing, compared to the broader…

Check up: 78 biotech companies rocked the boat this week but only one has real news

Things are starting to look up in the world of small-cap health companies with 78 gaining ground, 23 flatlining, and…

ASX Health Stocks: Opthea and Alterity to present at world renowned biotech conference

The ASX 200 Health Index (XHJ) is falling by 1.5% at the time of writing, compared to the broader index…

Guilty verdict for Theranos founder Elizabeth Holmes, but rapid blood testing still a hot sector on the ASX

Former Theranos CEO and founder Elizabeth Holmes has been convicted on four counts of fraud and conspiracy by a Northern…

ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece

The ASX 200 Health Index (XHJ) is trading higher by 0.30% at the time of writing, compared to the broader…

ASX Health Stocks: Mesoblast responds to questions arising from US FDA meeting

The ASX 200 Health Index (XHJ) is trading lower by 0.26% at the time of writing, compared to the broader…

‘Bring in the bulldozers’: Cynata’s CEO on how heavyweight FujiFilm will turbocharge its stem cells production

Stem cell therapy, sometimes called regenerative medicine, is one of the most exciting areas of the life sciences sector right…